Investors Buy Humana (HUM) on Weakness

Investors purchased shares of Humana Inc (NYSE:HUM) on weakness during trading on Thursday. $75.01 million flowed into the stock on the tick-up and $52.87 million flowed out of the stock on the tick-down, for a money net flow of $22.14 million into the stock. Of all equities tracked, Humana had the 33rd highest net in-flow for the day. Humana traded down ($1.23) for the day and closed at $275.02

Several analysts recently weighed in on the stock. Zacks Investment Research reiterated a “hold” rating and issued a $306.00 price target on shares of Humana in a report on Monday, December 31st. Barclays reiterated a “buy” rating and issued a $351.00 price target on shares of Humana in a report on Sunday. Cowen assumed coverage on shares of Humana in a report on Monday, September 17th. They issued a “market perform” rating and a $372.00 price target on the stock. Cantor Fitzgerald reiterated a “hold” rating and issued a $325.00 price target on shares of Humana in a report on Wednesday, January 2nd. Finally, Credit Suisse Group lifted their price target on shares of Humana from $370.00 to $390.00 and gave the company an “outperform” rating in a report on Thursday, November 8th. Seven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $354.63.

The firm has a market cap of $37.95 billion, a P/E ratio of 23.49, a price-to-earnings-growth ratio of 1.08 and a beta of 1.09. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.45.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 7th. The insurance provider reported $4.58 EPS for the quarter, beating the Zacks’ consensus estimate of $4.29 by $0.29. Humana had a net margin of 2.70% and a return on equity of 19.10%. The firm had revenue of $14.21 billion for the quarter, compared to analysts’ expectations of $13.97 billion. During the same quarter in the previous year, the business posted $3.39 EPS. As a group, equities analysts forecast that Humana Inc will post 14.43 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Stockholders of record on Monday, December 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Friday, December 28th. Humana’s dividend payout ratio (DPR) is presently 8.54%.

In other news, Director David A. Jr/Ky Jones sold 200 shares of Humana stock in a transaction dated Saturday, May 18th. The stock was sold at an average price of $230.04, for a total value of $46,008.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Roy A. Beveridge sold 4,622 shares of Humana stock in a transaction dated Thursday, November 8th. The stock was sold at an average price of $341.06, for a total value of $1,576,379.32. Following the completion of the transaction, the insider now directly owns 10,621 shares of the company’s stock, valued at approximately $3,622,398.26. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,078 shares of company stock worth $2,570,350. Company insiders own 0.60% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. Moody National Bank Trust Division purchased a new position in shares of Humana in the 4th quarter worth about $30,000. Matthew Goff Investment Advisor LLC purchased a new position in shares of Humana in the 3rd quarter worth about $64,000. IMS Capital Management purchased a new position in shares of Humana in the 3rd quarter worth about $68,000. Stratos Wealth Partners LTD. purchased a new position in shares of Humana in the 3rd quarter worth about $108,000. Finally, Honkamp Krueger Financial Services Inc. purchased a new position in shares of Humana in the 3rd quarter worth about $108,000. 92.69% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This report was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.com-unik.info/2019/01/10/investors-buy-humana-hum-on-weakness.html.

Humana Company Profile (NYSE:HUM)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Further Reading: Tariff

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit